3651 results for «328»

Filter By

3651 results

The importance of optimal vascular access and closure in TAVI patients

16 May 2023 – From EuroPCR 2023

In this session, a panel of experts focus on access and closure, a crucial aspect of TAVI. This discussion offers valuable insights into effective planning and achieving access for a TAVI procedure using echo guidance. It provides a step-by-step guide on closing a TAVI procedure using...

The importance of optimal

From proof to practice - Treating hypertension with ultrasound renal denervation

16 May 2023 – From EuroPCR 2023

Renal denervation: what are the latest clinical evidences and benefits? How to select the good candidate? How to establish a dedicated centre? All the anwers to these questions and more in this video.

From proof to practice

Robotic PCI: real-life experience with a new robotic platform

16 May 2023 – From EuroPCR 2023

The current problems in interventional cardiology have been the same for years: exposure to X-rays, or orthopaedic injuries to operators after decades in the cathlab. The solution to these problems could lie in robotics and the increasing use of artificial intelligence in practice. Follow this session...

Robotic PCI: real-life

Lifetime management - Tailoring treatment options to secure future possibilities

16 May 2023 – From EuroPCR 2023

Check out this session if you want to better understand the importance of paravalvular leaks and conduction disorders after TAVI on long-term outcomes. You will also learn about the latest data on the lifetime management of patients with aortic stenosis, and value the importance of TAVI...

Lifetime management -

Physiologic guidance and optimisation in multivessel disease

16 May 2023 – From EuroPCR 2023

Follow the case study of this 70-year-old ex-smoker male patient with HTN, dyslipidemia, previous primary PCI to proximal and mid LAD because of anterolateral STEMI, presenting with syncope, and find out, through the debates around his treatment, how to use physiology in 2023.

Physiologic guidance

Going down the road of coronary artery disease treatment: sirolimus-coated balloon and DES + DCB stent platform

16 May 2023 – From EuroPCR 2023

What better way to talk about sirolimus-coated balloons than with real-life clinical cases? In this session, study the case of a 78-year-old man with crescendo angina and inferior wall ischaemia, or a 48-year-old woman with crescendo angina, type 2 DM and anterior wall hypokinesia with mild...

Going down the road of

EuroPCR 2023 Welcome Ceremony

16 May 2023 – From EuroPCR 2023

As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...

EuroPCR 2023 Welcome

Treating diverse mitral regurgitation anatomies: the power of versatility

16 May 2023 – From EuroPCR 2023

Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...

Treating diverse mitral regurgitation anatomies: the power of versatility

30 years of primary PCI – a tale of perseverance

16 May 2023

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

30 years of primary PCI – a tale of perseverance

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
Didn’t find what you were looking for?